Placebo coated tablet 002 to bay 948862 coated tablet

DRUG2 trials

Sponsors

The George Institute For Global Health

Conditions

Chronic Kidney DiseaseChronic kidney disease

Phase 3

The Chronic kidney disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect (CAPTIVATE)

WithdrawnCTIS2024-511325-67-00

The George Institute For Global HealthChronic kidney disease

Target: 300Updated: 2024-11-14

The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect (CAPTIVATE)

Not yet recruitingCTIS2024-520253-21-00

The George Institute For Global HealthChronic Kidney Disease

Target: 150Updated: 2025-09-16